<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>17803</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_pmc">17803</infon><infon key="article-id_pmid">11219389</infon><infon key="article-id_publisher-id">ar-2-1-050</infon><infon key="fpage">50</infon><infon key="issue">1</infon><infon key="journal-title">Arthritis Research</infon><infon key="kwd">B-lymphocyte repertoire complementarity determining region immunoglobulin variable region gene rheumatoid arthritis synovial tissue</infon><infon key="lpage">58</infon><infon key="name_0">surname:Itoh;given-names:Kenji</infon><infon key="name_1">surname:Patki;given-names:Varsha</infon><infon key="name_2">surname:Furie;given-names:Richard A</infon><infon key="name_3">surname:Chartash;given-names:Elliot K</infon><infon key="name_4">surname:Jain;given-names:Rita I</infon><infon key="name_5">surname:Lane;given-names:Lewis</infon><infon key="name_6">surname:Asnis;given-names:Stanley E</infon><infon key="name_7">surname:Chiorazzi;given-names:Nicholas</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2</infon><infon key="year">1999</infon><offset>0</offset><text>Clonal expansion is a characteristic feature of the B-cell repertoire 		  of patients with rheumatoid arthritis</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>112</offset><text>The aim of this study was to determine the extent of B-cell clonal diversity in patients with rheumatoid arthritis, using HCDR3 as a marker. They also used PCR techniques to identify and differentiate between numerically expanded and un-expanded B cells using genomic DNA or complementary (c)DNA from peripheral blood and synovial fluid, which allowed for the identification of various autoimmune reaction vectors. These results support the idea that cellular genetic information may be relevant in understanding the causes of immune responses in inflammatory markers like reder</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1653</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1666</offset><text>Clonal expansion is a common feature of the B-cell repertoire, whose repertoire of 854 distinct T-cell subtypes is divided into 3 main sub-categories:

i) B-cell subtypes with a specific repertoire of T-cell subtypes, which are the most abundant sub-categories of B-cells in the patient, and

ii) B-cell subtypes without a specific repertoire of T-cell subtypes, which are the most abundant sub-categories of B-cells in the patient.

Clonal expansion is also referred to as "clonal amplification" or "clonal acquisition" in the literature. However, in a recent study, it was shown that the term "clonal expansion" is misleading</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2559</offset><text>Support for T-cell involvement in rheumatoid arthritis includes the description of limited subsets of T cells in the blood and synovial tissue that either express or exclude certain surface membrane proteins or a limited repertoire of antigen receptors: For example, clonal recombination alterations of CD8+ CD57+ T cell repertoire are frequently observed in patients with RA; expanded cytoplasmic copies of tick (CD4+) CD28- T Cells in their rat host tissues and these cells show that these mice showed markedly low but high density receptor</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3326</offset><text>Unlike the detailed investigations into the clonal distribution of T cells in rheumatoid arthritis, there is limited information about the extent to which B-cell diversity is present in this disease. However, previous studies indicate that the repertoire of B cells is also restricted. Examples include flow cytometry analysis of circulating B cell types, cell culture experiments, and evidence suggesting that immunoglobulins of restricted heterogeneity are secreted spontaneously by synovial tissue explants. Contemporary molecular analyses of immunopeptidin genes expressed by B</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4136</offset><text>This is important because, at B- and T-cell levels, an ongoing immune response occurs that is directed at restricted sets of (auto)antigens. To this end, we reformulated the immunoglobulin VH gene fingerprinting method using the length of the third complementarity determining region (CDR3) to study the level of clonal diversity in human RA cells; thus, our data points are more likely to indicate that B&#8211;cell expansion is a common feature of advanced rheumatoid arthritis, both the patient host host</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>5183</offset><text>Materials and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5205</offset><text>Patients and patient samples</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5234</offset><text>Heparinized venous blood, synovial fluid, and synovial tissue were 			 obtained from patients who fulfilled the American College of Rheumatology 			 criteria for the diagnosis of rheumatoid arthritis. 			 Synovial tissue removed at the time of either joint replacement or therapeutic 			 synovectomy was digested with collagenase, DNAse, and hyaluronidase to obtain 			 single-cell suspensions. Mononuclear cells (MNCs) were isolated from cell 			 suspensions from blood, synovial fluid, and synovial tissue by density gradient 			 centrifugation (Ficoll-Paque; Pharmacia LKB Biotechnology, Piscataway, NJ, 			 USA).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5851</offset><text>Isolation of DNA and RNA, and preparation of complementary DNA</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5914</offset><text>Genomic DNA was isolated from MNCs using the Puregene DNA Isolation 			 Kit (Gentra Systems, Mineapolis, MN, USA) and total RNA was isolated using 			 Ultraspec RNA (Biotech Laboratories, Houston, TX, USA). Both of these reagents 			 were used according to the manufacturer's instructions. One microgram of 			 RNA was reverse transcribed to complementary (c)DNA using 200U Moloney murine 			 leukemia virua (M-MLV) reverse transcriptase (GIBCO BRL Life Technologies, 			 Grand Island, NY, USA), 1U RNAse inhibitor (5 Prime 3 Prime, Boulder, CO, USA) 			 and 20 pmol oligo dT primer in a total volume of 20 &#956;l. These ingredients 			 were incubated at 42&#176;C for 1 h, heated to 65&#176;C for 10 min to stop the 			 reactions, and then diluted to a final volume of 100 &#956;l.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6682</offset><text>Polymerase chain reaction conditions for immunoglobulin 				VH gene fingerprinting assay</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6771</offset><text>The original immunoglobulin VH gene fingerprinting assay was modified into two stages, starting with either 			 genomic DNA or cDNA as templates (Fig. 1). The sequences 			 of the primers used in these reactions were published previously.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>7010</offset><text>Stage I</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7018</offset><text>Genomic DNA (100ng) was amplified using a sense VH 				family-specific framework region (FR)1 primer in conjunction with an antisense 				JH consensus primer. These reactions were carried out in 50 &#956; l 				using 5 pmol of each primer, and were cycled with a 9600 GeneAmp System (Perkin 				Elmer, Emeryville, CA, USA) as follows: denaturation at 94&#176;C for 40 s; 				annealing at 65&#176;C for 45 s; and extension at 72&#176;C for 40 s. After 35 				cycles, extension was continued at 72&#176;C for an additional 10 min.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7527</offset><text>cDNA (2&#956;l) was amplified using a sense VH 				family-specific FR1 primer in conjunction with the appropriate antisense 				CH primer. The reactions were carried out in 50 &#956;l using 5 pmol 				of each primer and cycled as follows: denaturation at 94&#176;C for 45 s; 				annealing at 65&#176;C for 45 s; and extension at 72&#176;C for 45 s. After 35 				cycles, extension was continued at 72&#176;C for an additional 10 min.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>7936</offset><text>Stage II</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7945</offset><text>Polymerase chain reaction (PCR) products (2 &#956; l) generated 				from either genomic DNA or cDNA were amplified using 5 pmol of nested sense 				VH family-specific FR3 primer and radiolabeled antisense nested 				JH consensus primer that had been end-labeled with 				&#947;32-P (New England Nuclear, Beverly, MA, USA) using T4 				polynucleotide kinase (Promega, Madison, WI, USA). The reactions were carried 				out in 25 &#956; l and cycled as follows: denaturation at 94&#176;C for 30 s; 				annealing at 52&#176;C for 45 s; and extension at 72&#176;C for 30 s. After 15 				cycles, extension was continued at 72&#176;C for an additional 10 min. The 				radiolabeled PCR products that reflected the HCDR3 lengths of various B-cell 				clones in the cell suspension were electrophoresed through a 6% denaturing 				acrylamide sequencing gel for approximately 1.5 h. The gel was then dried and 				exposed to film overnight.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8847</offset><text>DNA cloning and sequencing</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8874</offset><text>DNA sequences were determined by reamplifying the original genomic 			 DNA using the appropriate family-specific VH leader and 			 JH consensus primers under the following PCR conditions: 			 denaturation at 94&#176;C for 45s; annealing at 62&#176;C for 30s; and 			 extension at 72&#176;C for 45s. After 35 cycles, extension was continued at 			 72&#176;C for an additional 10min. PCR products were then cloned into TA vector 			 (Invitrogen, San Diego, CA, USA), processed using Wizard minipreps (Promega), 			 and sequenced using M13 forward and reverse primers, a DNA Sequencing Kit 			 (Perkin Elmer) and an automated sequenator (Applied Biosystems, Foster City, 			 CA, USA).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>9540</offset><text>Results and discussion</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>9563</offset><text>Identification of B-cell clonal expansions using a modified 				immunoglobulin VH gene fingerprinting assay</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9671</offset><text>During normal B cell development, the processes of gene segment 			 recombination and coding end processing yield nucleotide HCDR3 lengths that are 			 characteristic and virtually invariant for an individual B-cell clone. 			 Therefore, these lengths can be used as signatures to identify members of a B 			 cell clone. The immunoglobulin VH gene fingerprinting approach takes advantage of the wide range of HCDR3 lengths 			 that can occur in human B cells (approximately 5-35 amino acids) to provide an 			 estimate of clonal diversity in polyclonal populations. When polyclonal B 			 lymphocytes from adults are analyzed using this assay, they display a Gaussian 			 HCDR3 length distribution around a mean of approximately 15 amino acids. The 			 presence of an individual dominant length that differs from this Gaussian 			 distribution can be used as an indication of a specific B-cell clonal 			 expansion.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10586</offset><text>Figure 1 illustrates schematically the 			 two-stage immunoglobulin VH gene fingerprinting approach that we 			 utilized. Note that when cDNA prepared from normal peripheral blood B cells is 			 used as a template for these VH family-specific and 			 CH-specific assays, ladders of HCDR3 lengths that differ by three 			 nucleotides are identified. These individual HCDR3 lengths are signatures of 			 the various individual B-cell clones contained within the polyclonal 			 population. The intensities of the bands in virtually all of the ladders 			 illustrated in Figure 1 are relatively uniformly 			 distributed around the mean. This indicates that there are no dominant HCDR3 			 lengths that skew the Gaussian distribution, and therefore that there are no 			 significant clonal expansions among the B cells that express most of these 			 VH&#8211;CH combinations. Similar results are obtained using 			 the genomic DNA-based assay, although these results cannot be interpreted in a 			 CH-specific manner (data not shown).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11613</offset><text>In the VH6-IgG combination (Fig. 1), however, a non-Gaussian distribution is noted, even in this 			 normal individual. This could be a reflection of the numbers of VH 			 genes present in the VH family being analyzed (it is more likely to 			 see a non-Gaussian distribution in families with small numbers of individual 			 genes) or of the state of activation of a specific clone (because activated B 			 cells contain much higher levels of V gene messenger RNA than resting B cells). 			 We believe that in the instance illustrated in Figure 1 			 the latter possibility is more likely, because the small VH2 and 			 VH5 families (only two gene members per family) do not exhibit the 			 same degree of oligoclonality as that observed with the only somewhat smaller 			 VH6 family (one gene member).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>12416</offset><text>Distinction between clonal expansion and clonal activation using 				the modified immunoglobulin VH gene fingerprinting assay</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12542</offset><text>Because B-cell activation and differentiation result in dramatic 			 increases in immunoglobulin V gene messenger RNA, these fingerprinting assays 			 cannot readily distinguish between clonal expansion and activation when cDNA is 			 used as a starting template. Because DNA levels are not appreciably altered by 			 cellular activation, however, the use of genomic DNA as well as cDNA from the 			 same sample of B cells helps to distinguish these two processes.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13007</offset><text>Thus, in the setting of specific B-cell clonal expansion without 			 concomitant cellular activation, the DNA-based fingerprinting assay will 			 indicate a dominant HCDR3 length, whereas the cDNA-based assay may not (data 			 not shown). Conversely, in the setting of specific B-cell clonal activation 			 without concomitant clonal expansion, the cDNA-based assay will indicate a 			 dominant HCDR3 length, whereas the DNA-based assay may not. Finally, in the 			 setting of specific B-cell clonal activation with concomitant clonal expansion, 			 both the cDNA- and the DNA-based assays will indicate a dominant HCDR3 			 length.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13640</offset><text>These distinctions were very reproducible in the following studies. 			 There were no situations in which evidence for cellular activation (either 			 selective or accompanied by clonal expansion) was present in one set of 			 analyses and not in a subsequent set using the same starting materials.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13939</offset><text>B cells in the blood, synovial fluid, and synovial tissue of 				rheumatoid arthritis patients exhibit clonal expansions of activated and 				resting B cells</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14097</offset><text>We analyzed the peripheral blood, synovial fluid, and synovial 			 tissue B cells of rheumatoid arthritis patients (n = 20, 10, and 5, 			 respectively) using the genomic DNA- and cDNA-based fingerprinting assays to 			 develop an understanding of the diversity of the B cells in these compartments. 			 Figures 2 and 3 are illustrations 			 of representative patients for whom concomitant blood and synovial fluid or 			 blood and synovial tissue samples were available. In order to simplify the 			 Figures, only the results for two large VH families (VH1 			 and VH3) and two small VH families (VH5 and 			 VH6) are provided, although assays for each VH family and 			 each major CH family (&#956;,&#947;, and &#945;) were performed and revealed 			 similar findings.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14862</offset><text>The genomic DNA-based assays in both patients indicated that clonal 			 expansions are common in the blood of rheumatoid arthritis patients. This type 			 of result was obtained with all individuals tested. It was most convincingly 			 demonstrated by the results in Figure 3 obtained from B 			 cells expressing genes of the VH1 and VH3 families. 			 Because these VH families contain the largest numbers of 			 VH genes, they would be more likely to display a polyclonal 			 pattern.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15348</offset><text>An even more striking level of B-cell clonal dominance and expansion 			 was seen when the genomic DNA-based assay was used to analyze B cells from the 			 synovial fluid or synovial tissue (Figs 2 and 			 3). In these analyses, virtually all VH 			 families demonstrated extensive B-cell oligoclonality. It should be pointed out 			 that when an individual HCDR3 length comprises more than 50% of the radioactive 			 counts of a VH&#8211;CH ladder, clonality, based on DNA 			 sequencing, is very likely; when an individual length comprises more than 70% 			 of the radioactivity, clonality is virtually assured (data not shown).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15975</offset><text>Collectively, these data indicate that the B-cell repertoire of 			 rheumatoid arthritis patients is skewed away from the typical, apparently 			 random representation of normal individuals. The reason for this discrepancy is 			 not clear, although one possibility is that restricted antigenic exposure 			 alters the composition of the repertoire in favor of B cells reactive with the 			 putative antigen(s). If this is so, the progressive narrowing of the repertoire 			 from the blood to the synovial tissue is consistent with the ideas that the 			 antigenic exposures are originating at these sites and that the synovial 			 compartment is supporting clonal amplification. Because these are true clonal 			 expansions (ie increased numbers of B cells per specific clone), it is likely 			 that the antigenic exposures are chronic and therefore are increasing the 			 numbers of memory B cells reactive with these determinants.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16909</offset><text>In order to confirm that these clonally expanded B cells were 			 receiving ongoing antigenic stimulation and not limited solely to the memory 			 compartment, we employed the cDNA-based assay to distinguish clonal expansions 			 of activated B cells from resting (memory) cells. As illustrated in Figure 			 2, activated B-cell clones (identified by the letter 			 'A' in Fig. 2) expressing each of the 			 immunoglobulin heavy-chain isotypes were easily identified in all the 			 VH families studied. In some instances, these activated clones were 			 also expanded numerically (as defined by the genomic DNA-based assays, and 			 identified by the letter 'E' in Fig. 2). In 			 other cases, these activated clones did not appear to be numerically expanded. 			 Similar examples can be found in Figures 3 and 			 4, but they are not identified by letters in order to 			 simplify the Figures. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17805</offset><text>Thus, it appears that many discrete B-cell clones exist in the 			 synovial compartment of rheumatoid arthritis patients, and that these are 			 increased in number, consistent with a response to a restricted antigenic 			 challenge(s). Furthermore, these B-cell clones appear to be of both the resting 			 (memory) and the activated types, suggesting that these antigenic challenges 			 are chronic and ongoing. Thus, these data support and extend previous findings by 			 indicating that specific B-cell clonal amplifications can occur both in 			 previously stimulated B cells and in currently activated B cells. The presence 			 of activated B cells that are not increased in number is consistent either with 			 recent in situ synovium-specific stimulation of these B-cell clones, 			 or with the influx of activated B cells that were stimulated by antigens 			 outside of and not necessarily relevant to the synovial compartment.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>18741</offset><text>B-cell clonal expansions in the blood and synovial compartments 				can be restricted to one or another compartment, or be common to the two</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18882</offset><text>Because the preceding data indicated that the B-cell repertoire of 			 rheumatoid arthritis patients contains expanded clones of B cells that can be 			 resting or activated, we investigated whether the same clones could be 			 identified in both the blood and synovial compartments. Figures 2 and 3 illustrate data that suggest that 			 there are expanded clones that are blood restricted, joint restricted, or are 			 common to both compartments. Examples of blood-restricted clones are 			 highlighted on Figures 2 and 3 with 			 the &#9656; symbol, those that are joint-restricted with the &#9657; symbol, and those 			 that are common to the two compartments with the &#9830; symbol. These findings 			 suggest that there may be a degree of cellular trafficking between the blood 			 and the synovial tissues.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19685</offset><text>In order to address this issue, we studied the B cells of the blood 			 and two synovial sites (right and left hip) that were obtained from the same 			 patient within 3 h of each other (Fig. 4). In this 			 patient, the DNA-based assay provided examples of clonal expansions that were 			 present in only one joint (eg the VH3&#8211;JH and 			 VH5&#8211;JH combinations in Figure 4), 			 and the companion cDNA-based assays indicated that in some instances these 			 expansions were either activated or resting. In only rare instances, however, 			 did the data suggest that a similar clone was present in two different synovial 			 tissues. DNA sequence analyses confirmed the rarity of this event (data not 			 shown). Thus it appears that in most instances the clonal amplifications occur 			 in situ and are not the result of trafficking from one anatomic site 			 to another. If so, this would suggest that the antigenic challenges driving 			 these clonal expansions may not be common to all synovial tissues, but may be 			 generated independently at each site, possibly by ongoing tissue breakdown.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>20785</offset><text>Clonal persistence in the synovial fluid compartment</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20838</offset><text>If the clonal expansions identified in the joints of rheumatoid 			 arthritis patients are due to an ongoing response to antigen, then one would 			 predict that at least some of the clones would persist over time. To test this, 			 we studied the synovial fluid B cells from the same joints of three patients on 			 two occasions spanning several months. Most of the clonal expansions detected 			 on the initial samples were not present in the subsequent samples. In a few 			 instances, however, B-cell clonal persistence was found.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21374</offset><text>Figure 5 illustrates the best example of this 			 phenomenon in a patient who was studied over a 4-month interval. The DNA-based 			 assay using VH4 family-specific primers indicated the presence of 			 two similar clones on days 0 and 120, whereas the other 			 VH4-expressing clones detected at the first analysis were 			 no longer present at the time of the second analysis. DNA sequence analyses of 			 one of these two clones confirmed their identity, because each displayed the 			 same rearranged VHDJH gene with identical VH 			 mutations and identical HCDR3 sequences (data not shown). Therefore, certain 			 clones can persist locally over time, suggesting that a common and persistent 			 antigenic stimulation was operable in the joint of this rheumatoid arthritis 			 patient.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>22165</offset><text>The lack of persistence of the other B-cell clones suggests two 			 possibilities. First, the initial set of B-cell clones might have been replaced 			 by others that recognized and responded to different antigenic epitopes on the 			 same original immunogenic protein. This type of clonal evolution to the 			 recognition of different epitopes on the same immunogenic moiety is common in 			 experimental situations in which repetitive immunizations with a defined 			 antigen are delivered. The other possibility is that 			 the B cells that disappeared over time were not reactive with tissue antigens. 			 These could have been stimulated by irrelevant antigens in the periphery and 			 therefore, after entering the synovial compartment, could not be restimulated 			 and hence could not enter the memory pool and take up residence in the synovial 			 tissue.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>23030</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>23041</offset><text>The data suggest that clonal expansion is a frequent occurrence in the B-cell repertoire of patients with rheumatoid arthritis. This process involves both resting memory B cells and activated B cell types, some of which are derived from the memory (and thus may not be directly affected) as well as developing locally due to alterations in their local tissue composition.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>24053</offset><text>Recent research has revealed that the synovial tissue of rheumatoid arthritis patients can develop lymphoidic aggregates that contain the cellular components of an ectopic germinal center and can support B-cell clonal expansion and diversification. It is likely that these B cells, which mature in these 'pseudogerminal centers' and those that we have identified in our current studies, are responding to specific (auto)antigens. Therefore, the identification of antigenic reactivations of these active B cell</text></passage><passage><infon key="fpage">1277</infon><infon key="lpage">1289</infon><infon key="name_0">surname:Harris;given-names:ED;suffix:Jr</infon><infon key="pub-id_pmid">2271017</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">322</infon><infon key="year">1990</infon><offset>24933</offset><text>Rheumatoid arthritis. Pathophysiology and implications for 			 therapy.</text></passage><passage><infon key="fpage">307</infon><infon key="lpage">310</infon><infon key="name_0">surname:Feldmann;given-names:M</infon><infon key="name_1">surname:Brennan;given-names:FM</infon><infon key="name_2">surname:Maini;given-names:RN</infon><infon key="pub-id_pmid">8616886</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">85</infon><infon key="year">1996</infon><offset>25005</offset><text>Rheumatoid arthritis.</text></passage><passage><infon key="fpage">768</infon><infon key="lpage">773</infon><infon key="name_0">surname:Firestein;given-names:GS</infon><infon key="name_1">surname:Zvaifler;given-names:NJ</infon><infon key="pub-id_pmid">2194461</infon><infon key="section_type">REF</infon><infon key="source">Arthritis Rheum</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">1990</infon><offset>25027</offset><text>How important are T cells in chronic rheumatoid synovitis?</text></passage><passage><infon key="fpage">5762</infon><infon key="lpage">5769</infon><infon key="name_0">surname:Hingorani;given-names:R</infon><infon key="name_1">surname:Choi;given-names:IH</infon><infon key="name_2">surname:Akolkar;given-names:P</infon><infon key="pub-id_pmid">8228260</infon><infon key="section_type">REF</infon><infon key="source">J Immunol</infon><infon key="type">ref</infon><infon key="volume">151</infon><infon key="year">1993</infon><offset>25086</offset><text>Clonal predominance of T cell receptors within the CD8+ 			 CD45RO+ subset in normal human subjects.</text></passage><passage><infon key="fpage">2068</infon><infon key="lpage">2076</infon><infon key="name_0">surname:Goronzy;given-names:JJ</infon><infon key="name_1">surname:Bartz-Bazzanella;given-names:P</infon><infon key="name_2">surname:Hu;given-names:W</infon><infon key="pub-id_pmid">7962553</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">1994</infon><offset>25187</offset><text>Dominant clonotypes in the repertoire of peripheral CD4+ 			 T cells in rheumatoid arthritis.</text></passage><passage><infon key="fpage">2027</infon><infon key="lpage">2037</infon><infon key="name_0">surname:Schmidt;given-names:D</infon><infon key="name_1">surname:Goronzy;given-names:JJ</infon><infon key="name_2">surname:Weyand;given-names:CM</infon><infon key="pub-id_pmid">8621791</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">1996</infon><offset>25281</offset><text>CD4+ CD7- CD28- T cells are expanded in rheumatoid 			 arthritis and are characterized by autoreactivity.</text></passage><passage><infon key="fpage">1179</infon><infon key="lpage">1183</infon><infon key="name_0">surname:Stamenkovic;given-names:I</infon><infon key="name_1">surname:Stegagno;given-names:M</infon><infon key="name_2">surname:Wright;given-names:KA</infon><infon key="pub-id_pmid">2963340</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">85</infon><infon key="year">1988</infon><offset>25387</offset><text>Clonal dominance among T-lymphocyte infiltrates in arthritis.</text></passage><passage><infon key="fpage">1555</infon><infon key="lpage">1557</infon><infon key="name_0">surname:Keystone;given-names:EC</infon><infon key="name_1">surname:Minden;given-names:M</infon><infon key="name_2">surname:Klock;given-names:R</infon><infon key="pub-id_pmid">2904267</infon><infon key="section_type">REF</infon><infon key="source">Arthritis Rheum</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1988</infon><offset>25449</offset><text>Structure of T cell antigen receptor beta chain in synovial fluid 			 cells from patients with rheumatoid arthritis.</text></passage><passage><infon key="fpage">6206</infon><infon key="lpage">6210</infon><infon key="name_0">surname:Duby;given-names:AD</infon><infon key="name_1">surname:Sinclair;given-names:AK</infon><infon key="name_2">surname:Osborne-Lawrence;given-names:SL</infon><infon key="pub-id_pmid">2548202</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="year">1989</infon><offset>25566</offset><text>Clonal heterogeneity of synovial fluid T lymphocytes from patients 			 with rheumatoid arthritis.</text></passage><passage><infon key="fpage">325</infon><infon key="lpage">329</infon><infon key="name_0">surname:Paliard;given-names:X</infon><infon key="name_1">surname:West;given-names:SG</infon><infon key="name_2">surname:Lafferty;given-names:JA</infon><infon key="pub-id_pmid">1857971</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">253</infon><infon key="year">1991</infon><offset>25664</offset><text>Evidence for the effects of a superantigen in rheumatoid 			 arthritis.</text></passage><passage><infon key="fpage">2525</infon><infon key="lpage">2531</infon><infon key="name_0">surname:Li;given-names:Y</infon><infon key="name_1">surname:Sun;given-names:GR</infon><infon key="name_2">surname:Tumang;given-names:JR</infon><infon key="name_3">surname:Crow;given-names:MK</infon><infon key="name_4">surname:Friedman;given-names:SM</infon><infon key="pub-id_pmid">7989613</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">1994</infon><offset>25736</offset><text>CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis 			 synovial T cells. Evidence for an antigen-driven response.</text></passage><passage><infon key="fpage">852</infon><infon key="lpage">858</infon><infon key="name_0">surname:Hingorani;given-names:R</infon><infon key="name_1">surname:Monteiro;given-names:J</infon><infon key="name_2">surname:Furie;given-names:R</infon><infon key="pub-id_pmid">8543842</infon><infon key="section_type">REF</infon><infon key="source">J Immunol</infon><infon key="type">ref</infon><infon key="volume">156</infon><infon key="year">1996</infon><offset>25863</offset><text>Oligoclonality of V beta 3 TCR chains in the CD8+ T cell 			 population of rheumatoid arthritis patients.</text></passage><passage><infon key="fpage">991</infon><infon key="lpage">995</infon><infon key="name_0">surname:Fox;given-names:DA</infon><infon key="name_1">surname:Smith;given-names:BR</infon><infon key="pub-id_pmid">3101621</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">1986</infon><offset>25969</offset><text>Evidence for oligoclonal B cell expansion in the peripheral blood of 			 patients with rheumatoid arthritis.</text></passage><passage><infon key="fpage">136</infon><infon key="lpage">144</infon><infon key="name_0">surname:Hoffman;given-names:WL</infon><infon key="name_1">surname:Goldberg;given-names:MS</infon><infon key="name_2">surname:Smiley;given-names:JD</infon><infon key="pub-id_pmid">7054235</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1982</infon><offset>26078</offset><text>Immunoglobulin G3 subclass production by rheumatoid synovial tissue 			 cultures.</text></passage><passage><infon key="fpage">1196</infon><infon key="lpage">1204</infon><infon key="name_0">surname:Hoffman;given-names:WL</infon><infon key="name_1">surname:Jump;given-names:AA</infon><infon key="name_2">surname:Smiley;given-names:JD</infon><infon key="pub-id_pmid">2390125</infon><infon key="section_type">REF</infon><infon key="source">Arthritis Rheum</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">1990</infon><offset>26160</offset><text>Synthesis of specific IgG idiotypes by rheumatoid synovium.</text></passage><passage><infon key="fpage">151</infon><infon key="lpage">162</infon><infon key="name_0">surname:Smiley;given-names:JD</infon><infon key="name_1">surname:Hoffman;given-names:WL</infon><infon key="name_2">surname:Moore;given-names:SE</infon><infon key="name_3">surname:Paradies;given-names:LH</infon><infon key="pub-id_pmid">3909402</infon><infon key="section_type">REF</infon><infon key="source">Semin Arthritis Rheum</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">1985</infon><offset>26220</offset><text>The humoral immune response of the rheumatoid synovium.</text></passage><passage><infon key="fpage">742</infon><infon key="lpage">752</infon><infon key="name_0">surname:Wernick;given-names:RM</infon><infon key="name_1">surname:Lipsky;given-names:PE</infon><infon key="name_2">surname:Marban-Arcos;given-names:E</infon><infon key="pub-id_pmid">4015721</infon><infon key="section_type">REF</infon><infon key="source">Arthritis Rheum</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">1985</infon><offset>26276</offset><text>IgG and IgM rheumatoid factor synthesis in rheumatoid synovial 			 membrane cell cultures.</text></passage><passage><infon key="fpage">631</infon><infon key="lpage">641</infon><infon key="name_0">surname:Bridges;given-names:SL;suffix:Jr</infon><infon key="name_1">surname:Lee;given-names:SK</infon><infon key="name_2">surname:Koopman;given-names:WJ</infon><infon key="name_3">surname:Schroeder;given-names:HW;suffix:Jr</infon><infon key="pub-id_pmid">8489540</infon><infon key="section_type">REF</infon><infon key="source">Arthritis Rheum</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">1993</infon><offset>26367</offset><text>Analysis of immunoglobulin gamma heavy chain expression in synovial 			 tissue of a patient with rheumatoid arthritis.</text></passage><passage><infon key="fpage">450</infon><infon key="lpage">452</infon><infon key="name_0">surname:Bridges;given-names:SL;suffix:Jr</infon><infon key="name_1">surname:Clausen;given-names:BE</infon><infon key="name_2">surname:Lavelle;given-names:JC</infon><infon key="pub-id_pmid">7486563</infon><infon key="section_type">REF</infon><infon key="source">Ann N Y Acad Sci</infon><infon key="type">ref</infon><infon key="volume">764</infon><infon key="year">1995</infon><offset>26486</offset><text>Analysis of immunoglobulin gamma heavy chains from rheumatoid 			 arthritis synovium. Evidence of antigen-driven selection.</text></passage><passage><infon key="fpage">221</infon><infon key="lpage">225</infon><infon key="name_0">surname:Schroder;given-names:AE</infon><infon key="name_1">surname:Greiner;given-names:A</infon><infon key="name_2">surname:Seyfert;given-names:C</infon><infon key="name_3">surname:Berek;given-names:C</infon><infon key="pub-id_pmid">8552609</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">93</infon><infon key="year">1996</infon><offset>26610</offset><text>Differentiation of B cells in the nonlymphoid tissue of the synovial 			 membrane of patients with rheumatoid arthritis.</text></passage><passage><infon key="fpage">423</infon><infon key="lpage">426</infon><infon key="name_0">surname:Bridges;given-names:SL;suffix:Jr</infon><infon key="name_1">surname:Lavelle;given-names:JC</infon><infon key="name_2">surname:Lee;given-names:SK</infon><infon key="name_3">surname:Byer;given-names:S</infon><infon key="name_4">surname:Schroeder;given-names:HW;suffix:Jr</infon><infon key="pub-id_pmid">9186688</infon><infon key="section_type">REF</infon><infon key="source">Ann N Y Acad Sci</infon><infon key="type">ref</infon><infon key="volume">815</infon><infon key="year">1997</infon><offset>26731</offset><text>CDR3 fingerprinting of immunoglobulin kappa light chains expressed 			 in rheumatoid arthritis. Evidence of antigenic selection or dysregulation of 			 gene rearrangement in B cells.</text></passage><passage><infon key="fpage">261</infon><infon key="lpage">268</infon><infon key="name_0">surname:Berek;given-names:C</infon><infon key="name_1">surname:Kim;given-names:HJ</infon><infon key="pub-id_pmid">9237933</infon><infon key="section_type">REF</infon><infon key="source">Semin Immunol</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1997</infon><offset>26914</offset><text>B-cell activation and development within chronically inflamed 			 synovium in rheumatoid and reactive arthritis.</text></passage><passage><infon key="fpage">274</infon><infon key="lpage">281</infon><infon key="name_0">surname:Deane;given-names:M</infon><infon key="name_1">surname:Norton;given-names:JD</infon><infon key="pub-id_pmid">2012750</infon><infon key="section_type">REF</infon><infon key="source">Br J Haematol</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">1991</infon><offset>27027</offset><text>Immunoglobulin gene 'fingerprinting': an approach to 			 analysis of B lymphoid clonality in lymphoproliferative disorders.</text></passage><passage><infon key="fpage">2209</infon><infon key="lpage">2217</infon><infon key="name_0">surname:Deane;given-names:M</infon><infon key="name_1">surname:Norton;given-names:JD</infon><infon key="pub-id_pmid">1700749</infon><infon key="section_type">REF</infon><infon key="source">Eur J Immunol</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">1990</infon><offset>27151</offset><text>Immunoglobulin heavy chain variable region family usage is 			 independent of tumor cell phenotype in human B lineage leukemias.</text></passage><passage><infon key="fpage">1586</infon><infon key="lpage">1594</infon><infon key="name_0">surname:Dono;given-names:M</infon><infon key="name_1">surname:Hashimoto;given-names:S</infon><infon key="name_2">surname:Fais;given-names:F</infon><infon key="pub-id_pmid">8608251</infon><infon key="section_type">REF</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">87</infon><infon key="year">1996</infon><offset>27280</offset><text>Evidence for progenitors of chronic lymphocytic leukemia B cells 			 that undergo intraclonal differentiation and diversification.</text></passage><passage><infon key="fpage">1659</infon><infon key="lpage">1666</infon><infon key="name_0">surname:Fais;given-names:F</infon><infon key="name_1">surname:Sellars;given-names:B</infon><infon key="name_2">surname:Ghiotto;given-names:F</infon><infon key="pub-id_pmid">8833916</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">98</infon><infon key="year">1996</infon><offset>27411</offset><text>Examples of in vivo isotype class switching in IgM+ chronic 			 lymphocytic leukemia B cells. </text></passage><passage><infon key="fpage">315</infon><infon key="lpage">324</infon><infon key="name_0">surname:Arnett;given-names:FC</infon><infon key="name_1">surname:Edworthy;given-names:SM</infon><infon key="name_2">surname:Bloch;given-names:DA</infon><infon key="pub-id_pmid">3358796</infon><infon key="section_type">REF</infon><infon key="source">Arthritis Rheum</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1988</infon><offset>27506</offset><text>The American Rheumatism Association 1987 revised criteria for the 			 classification of rheumatoid arthritis.</text></passage><passage><infon key="fpage">1515</infon><infon key="lpage">1525</infon><infon key="name_0">surname:Fais;given-names:F</infon><infon key="name_1">surname:Ghiotto;given-names:F</infon><infon key="name_2">surname:Hashimoto;given-names:S</infon><infon key="pub-id_pmid">9788964</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">1998</infon><offset>27616</offset><text>Chronic lymphocytic leukemia B cells express restricted sets of 			 mutated and unmutated antigen receptors.</text></passage><passage><infon key="fpage">1457</infon><infon key="lpage">1467</infon><infon key="name_0">surname:Gollogly;given-names:JR</infon><infon key="name_1">surname:Cathou;given-names:RE</infon><infon key="pub-id_pmid">4608009</infon><infon key="section_type">REF</infon><infon key="source">J Immunol</infon><infon key="type">ref</infon><infon key="volume">113</infon><infon key="year">1974</infon><offset>27725</offset><text>Sequential appearance of three different anti-fluorescein combining 			 sites in hyperimmunized rabbits: characterization by circular dichroism and 			 binding studies.</text></passage><passage><infon key="fpage">412</infon><infon key="lpage">418</infon><infon key="name_0">surname:Berek;given-names:C</infon><infon key="name_1">surname:Griffiths;given-names:GM</infon><infon key="name_2">surname:Milstein;given-names:C</infon><infon key="pub-id_pmid">3927173</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">316</infon><infon key="year">1985</infon><offset>27894</offset><text>Molecular events during maturation of the immune response to 			 oxazolone.</text></passage><passage><infon key="fpage">541</infon><infon key="lpage">544</infon><infon key="name_0">surname:Gaya;given-names:A</infon><infon key="name_1">surname:Nieto;given-names:A</infon><infon key="name_2">surname:Moreno;given-names:C</infon><infon key="name_3">surname:Vives;given-names:J</infon><infon key="pub-id_pmid">3733154</infon><infon key="section_type">REF</infon><infon key="source">Immunology</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">1986</infon><offset>27970</offset><text>Affinity maturation in the arsonate system: lack of dominance of 			 high-affinity antibody subpopulations.</text></passage><passage><infon key="fpage">481</infon><infon key="lpage">486</infon><infon key="name_0">surname:Randen;given-names:I</infon><infon key="name_1">surname:Mellbye;given-names:OJ</infon><infon key="name_2">surname:Forre;given-names:O</infon><infon key="name_3">surname:Natvig;given-names:JB</infon><infon key="pub-id_pmid">7725067</infon><infon key="section_type">REF</infon><infon key="source">Scand J Immunol</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">1995</infon><offset>28078</offset><text>The identification of germinal centres and follicular dendritic cell 			 networks in rheumatoid synovial tissue.</text></passage><passage><infon key="section_type">FIG</infon><infon key="type">title_1</infon><offset>28191</offset><text>Figures and Tables</text></passage><passage><infon key="file">ar-2-1-050-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>28210</offset><text>Schematic representation of the two-stage VH
				fingerprinting assay using either genomic DNA or complementary (c)DNA as
				templates. In stage I for the genomic DNA-based assay, genomic DNA was
				amplified using a sense VH family-specific FR1 primer in conjunction
				with an antisense JH consensus primer. For the cDNA-based assay,
				cDNA was amplified using a sense VH family-specific FR1 primer in
				conjunction with the appropriate antisense CH primer. In stage II, polymerase
				chain reaction (PCR) products generated from either genomic DNA or cDNA were
				amplified using a nested sense VH family-specific FR3 primer and a
				radiolabeled antisense nested JH consensus primer that had been
				end-labeled with &#947;32-P. The radiolabeled PCR products were
				electrophoresed through a 6% denaturing acrylamide sequencing gel, and then
				exposed to photographic film overnight. See text (Materials and methods) for
				further details. *Areas of coding end processing at the
				D-JH and VH-DJH junctions. The VH
				fingerprinting results displayed were derived with the cDNA-based assay.</text></passage><passage><infon key="file">ar-2-1-050-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>29324</offset><text>Analyses of paired samples of blood (B) and synovial fluid (SF) B
				cells from the same rheumatoid arthritis patient. Results using both the
				genomic DNA-based assay and the complementary (c)DNA-based assay for the three
				major immunoglobulin isotypes (M, G, and A) are shown. Note that certain
				clones, as represented by individual HCDR3 lengths, are restricted to the blood
				(&#9656;), others to the joint (&#9657;), and others are common to both compartments
				(&#9830;). E, expanded clone; A, activated clone; E+A, same clone that is both
				expanded and activated.</text></passage><passage><infon key="file">ar-2-1-050-3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>29899</offset><text>Analyses of paired samples of blood (B) and synovial tissue (ST) B
				cells from the same rheumatoid arthritis patient. Results using both the
				genomic DNA-based assay and the complementary (c)DNA-based assay for the three
				major immunoglobulin isotypes (M, G, and A) are shown. Certain clones are
				restricted to the blood (&#9656;), others to the joint (&#9657;), and others are common
				to both compartments (&#9830;).</text></passage><passage><infon key="file">ar-2-1-050-4.jpg</infon><infon key="id">F4</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>30320</offset><text>Analyses of B cells from paired samples of blood (B) and synovial
				tissue from both the right (R) and left (L) hips of the same rheumatoid
				arthritis patient. Results using both the genomic DNA-based assay and the
				complementary (c)DNA-based assay for the three major immunoglobulin isotypes
				(M, G, and A) are shown. R, clones that are restricted to the right hip joint;
				L, clones that are restricted to the left hip joint; R+L, clones that are
				common to both the right and left hip joints.</text></passage><passage><infon key="file">ar-2-1-050-5.jpg</infon><infon key="id">F5</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>30832</offset><text>Persistence of a synovial fluid B cell clone in the same joint for
				4 months. Arthrocentesis was performed on the same joint of the same patient on
				days 0 and 120. One of the B-cell clones identified in each of these samples
				was identical in both HCDR3 length and in VHDJH gene DNA
				sequence.</text></passage></document></collection>